1.Regulatory Mechanisms of Thyrocyte Proliferation.
Jae Mi SUH ; Min Ho SHUNG ; Heung Kyu RO
Journal of Korean Society of Endocrinology 2002;17(3):325-337
No abstract available.
2.Prognostic Value of Baseline Neutrophilto-Lymphocyte Ratio Combined With Anemia in Patients With ST-Segment Elevation Myocardial Infarction: A Nationwide Prospective Cohort Study
Kyung Hoon CHO ; Min-Ho SHIN ; Min Chul KIM ; Doo Sun SIM ; Young Joon HONG ; Ju Han JU HAN ; Youngkeun AHN ; Shung Chull CHAE ; In Whan SEONG ; Jong-Seon PARK ; Chang-Hwan V ; Seung Ho HUR ; Sang Rok LEE ; Myung Ho JEONG ; On behalf of the Korea Acute Myocardial Infarction Registry-National Institutes of Health (KAMIR-NIH
Journal of Lipid and Atherosclerosis 2022;11(2):147-160
Objective:
Data pertaining to the prognostic value of the combination of high neutrophilto-lymphocyte ratio (NLR) and anemia on admission in patients with ST-segment elevation myocardial infarction (STEMI) are limited. The objective of this study was to investigate the clinical value of baseline NLR in combination with anemia in predicting clinical outcomes after STEMI.
Methods:
A total of 5,194 consecutive patients with STEMI within 12 hours of symptom onset from the Korea Acute Myocardial Infarction Registry-National Institute of Health database between 2011 and 2015 were categorized into 4 groups according to their NLR and hemoglobin levels: low NLR (<4) without anemia (n=2,722; reference group); high NLR (≥4) without anemia (n=1,527); low NLR with anemia (n=508); and high NLR with anemia (n=437). The co-primary outcomes were 180-day and 3-year all-cause mortality.
Results:
Mortality rates significantly increased at the 3-year follow-up across the groups (3.3% vs. 5.4% vs. 16.5% vs. 21.7% for 180-day mortality and 5.3% vs. 9.0% vs. 23.8% vs. 33.4% for 3-year mortality; all p-trends <0.001). After adjusting for baseline covariates, the combination of high NLR and anemia was a significant predictor of 180-day mortality after STEMI with low NLR and no anemia as the reference (adjusted hazard ratio, 2.16; 95% confidence interval, 1.58–2.95; p<0.001). Similar findings were observed for the 3-year mortality.
Conclusions
This nationwide prospective cohort study showed that the combination of high NLR (≥4) and anemia is a strong predictor of all-cause mortality after STEMI.
3.2020 Korean Society of Myocardial Infarction Expert Consensus Document on Pharmacotherapy for Acute Myocardial Infarction
Hyun Kuk KIM ; Youngkeun AHN ; Kiyuk CHANG ; Young-Hoon JEONG ; Joo-Yong HAHN ; Eun Ho CHOO ; Min Chul KIM ; Hyo-Soo KIM ; Weon KIM ; Myeong-Chan CHO ; Yangsoo JANG ; Chong Jin KIM ; Myung Ho JEONG ; Shung Chull CHAE ;
Korean Circulation Journal 2020;50(10):845-866
Clinical practice guidelines published by the European Society of Cardiology and the American College of Cardiology/American Heart Association summarize the available evidence and provide recommendations for health professionals to enable appropriate clinical decisions and improve clinical outcomes for patients with acute myocardial infarction (AMI). However, most current guidelines are based on studies in non-Asian populations in the pre-percutaneous coronary intervention (PCI) era. The Korea Acute Myocardial Infarction Registry is the first nationwide registry to document many aspects of AMI from baseline characteristics to treatment strategies. There are well-organized ongoing and published randomized control trials especially for antiplatelet therapy among Korean patients with AMI. Here, members of the Task Force of the Korean Society of Myocardial Infarction review recent published studies during the current PCI era, and have summarized the expert consensus for the pharmacotherapy of AMI.
4.Prevalence rate and triggering factors of syncope in medical students.
Byoung Jin CHANG ; Hyeon Min RYU ; Jang Hoon LEE ; Jae Kook SHIN ; Yong Seop KWON ; Hyun Sang LEE ; Seung Chul SHIN ; Hyung Seop KIM ; Jeong Ho HEO ; Dong Heon YANG ; Hun Sik PARK ; Yongkeun CHO ; Shung Chull CHAE ; Jae Eun JUN ; Wee Hyun PARK
Korean Journal of Medicine 2004;67(4):398-403
BACKGROUND: Syncope is a sudden and brief loss of consciousness associated with a loss of postural tone, from which recovery is spontaneous. The most frequently identified causes of syncope are neurocardiogenic, cardiac, cerebrovascular and side effects of drugs. However, in many cases, it is not easy to make a diagnosis of syncope. The prevalence rate of syncope also is variable according to the nature of the study. We investigated the prevalence rate, characteristics and triggering factors of syncope in young medical students. METHODS: We contacted 400 medical students of Kyungpook National University, Daegu, Korea, and a questionnaire on the prevalence, triggering factors, and recurrence rate of syncope was handed out. The data from 379 medical student (male 168, female 211, mean age 22.3 years) were included for further analysis. RESULTS: Fifty-eight students (15.3%) experienced syncope and female students reported higher prevalence rate than male students (20.4 versus 8.9%, p=0.002). Among 58 students with syncopal history, 22 students (male 2, female 20) experienced recurrent syncope. The students who experienced recurrent syncope were younger at first syncope than those without recurrent syncope (15.0 versus 17.3 years, p=0.039). The triggering factors of syncope were prolonged standing, warm environment, immediate standing, tiredness, emotional upset, menstruation, and so on. CONCLUSION: The prevalence rate of syncope was 15% in medical student with mean age of 22.3 years. As the syncope in female and early onset syncope showed higher rate of recurrence, more attention may prevent recurrent syncope in these cases.
Daegu
;
Diagnosis
;
Female
;
Gyeongsangbuk-do
;
Hand
;
Humans
;
Korea
;
Male
;
Menstruation
;
Prevalence*
;
Recurrence
;
Students, Medical*
;
Syncope*
;
Unconsciousness
;
Surveys and Questionnaires
5.Prognosis and Natural History of Drug-Related Bradycardia.
Jang Hoon LEE ; Hyeon Min RYU ; Myung Hwan BAE ; Yong Seop KWON ; Ju Hwan LEE ; Yongwhi PARK ; Jung Ho HEO ; Young Soo LEE ; Dong Heon YANG ; Hun Sik PARK ; Yongkeun CHO ; Shung Chull CHAE ; Yoon Nyun KIM ; Jae Eun JUN ; Wee Hyun PARK
Korean Circulation Journal 2009;39(9):367-371
BACKGROUND AND OBJECTIVES: The prognosis and natural history of bradycardia related to drugs such as beta-blockers and non-dihydropyridine calcium channel blockers are not well known. SUBJECTS AND METHODS: We retrospectively analyzed 38 consecutive patients (age 69+/-11, 21 women) with drug-related bradycardia (DRB) between March 2005 and September 2007. A drug-associated etiology for the bradycardia was established based on the medical history and patient response to drug discontinuation. The mean follow-up duration was 18+/-8 months. RESULTS: The initial electrocardiogram (ECG) showed sinus bradycardia (heart rate < or =40/min) in 13 patients, sinus bradycardia with junctional escape beats in 18 patients, and third-degree atrioventricular (AV) block in seven patients. Drug discontinuation was followed by resolution of bradycardia in 60% of patients (n=23). Among them, five (17.8%) patients resumed taking the culprit medication after discharge and none developed bradycardia again. Bradycardia persisted in 10 (26.3%) patients despite drug withdrawal, and a permanent pacemaker was implanted in seven of them. Third-degree AV block, QRS width, and bradycardia requiring temporary transvenous pacing were significantly associated with the bradycardia caused by drugs. CONCLUSION: Beta-blockers were the most common drugs associated with DRB. However, in one quarter of the cases the DRB was not associated with drugs; in these patients permanent pacemaker implantation should be considered.
Arrhythmias, Cardiac
;
Atrioventricular Block
;
Bradycardia
;
Calcium Channel Blockers
;
Dichlororibofuranosylbenzimidazole
;
Electrocardiography
;
Follow-Up Studies
;
Humans
;
Natural History
;
Prognosis
;
Retrospective Studies
;
United Nations
6.The clinical significance of the differernce in left ventricular ejection fraction between rest and stress on gated myocardial perfusion SPECT.
Jae Kook SHIN ; Hyeon Min RYU ; Jang Hoon LEE ; Byoung Jin CHANG ; Yong Seop KWON ; Hyun Sang LEE ; Seung Chul SHIN ; Hyung Seop KIM ; Jeong Ho HEO ; Dong Heon YANG ; Byeong Cheol AHN ; Hun Sik PARK ; Yong Keun CHO ; Shung Chull CHAE ; Jae Eun JUN ; Wee Hyun PARK
Korean Journal of Medicine 2005;68(3):277-283
BACKGROUND: Gated myocardial perfusion SPECT improved diagnostic accuracy of coronary artery disease and enabled us to observe motion and thickening of myocardial walls, ejection fraction as well as myocardial perfusion. Many studies suggested that there was a decrease of left ventricular ejection fraction (LVEF) at post-stress compared with that at rest gated myocardial perfusion SPECT (stunning). The objective of this retrospective study is to evaluate the clinical significance of the decrease of LVEF at post-stress gated myocardial perfusion SPECT by correlating with coronary angiographic finding. METHODS: Authors selected 41 patients who underwent exercise electrocardiography and gated myocardial perfusion SPECT between May, 2001 and May, 2002. The patients underwent coronary angiography within 6 months. The patients were divided into two groups, 16 patients in whom post-stress LVEF was >or=5% lower than rest (stunning group) and 25 patients in whom LVEF was not >or=5% lower than rest (non-stunning group). RESULTS: The number of patients with hyperlipidemia was higher in stunning group than in non-stunning group (50% vs 4%, p=0.001). The number of patients with angiographic stenoses >90% was significantly higher in stunning group than in non-stunning group (75% vs 28%, p=0.04). The number of patients with multi-vessel disease was also significantly higher in stunning group than in non-stunning group (75% vs 36%, p=0.015). CONCLUSION: The patients who had a decreased LVEF after stress (stunning) showed more severe coronary artery stenosis. This finding suggests that stunning may be an important additional indicator of underlying myocardial ischemia.
Constriction, Pathologic
;
Coronary Angiography
;
Coronary Artery Disease
;
Coronary Stenosis
;
Electrocardiography
;
Humans
;
Hyperlipidemias
;
Myocardial Ischemia
;
Myocardial Stunning
;
Perfusion*
;
Retrospective Studies
;
Stroke Volume*
;
Tomography, Emission-Computed, Single-Photon*
7.Impact of the Metabolic Syndrome on the Clinical Outcome of Patients with Acute ST-Elevation Myocardial Infarction.
Min Goo LEE ; Myung Ho JEONG ; Youngkeun AHN ; Shung Chull CHAE ; Seung Ho HUR ; Taek Jong HONG ; Young Jo KIM ; In Whan SEONG ; Jei Keon CHAE ; Jay Young RHEW ; In Ho CHAE ; Myeong Chan CHO ; Jang Ho BAE ; Seung Woon RHA ; Chong Jin KIM ; Donghoon CHOI ; Yang Soo JANG ; Junghan YOON ; Wook Sung CHUNG ; Jeong Gwan CHO ; Ki Bae SEUNG ; Seung Jung PARK
Journal of Korean Medical Science 2010;25(10):1456-1461
We sought to determine the prevalence of metabolic syndrome (MS) in patients with acute myocardial infarction and its effect on clinical outcomes. Employing data from the Korea Acute Myocardial Infarction Registry, a total of 1,990 patients suffered from acute ST-elevation myocardial infarction (STEMI) between November 2005 and December 2006 were categorized according to the National Cholesterol Education Program-Adult Treatment Panel III criteria of MS. Primary study outcomes included major adverse cardiac events (MACE) during one-year follow-up. Patients were grouped based on existence of MS: group I: MS (n=1,182, 777 men, 62.8+/-12.3 yr); group II: Non-MS (n=808, 675 men, 64.2+/-13.1 yr). Group I showed lower left ventricular ejection fraction (LVEF) (P=0.005). There were no differences between two groups in the coronary angiographic findings except for multivessel involvement (P=0.01). The incidence of in-hospital death was higher in group I than in group II (P=0.047), but the rates of composite MACE during one-year clinical follow-up showed no significant differences. Multivariate analysis showed that low LVEF, old age, MS, low high density lipoprotein cholesterol and multivessel involvement were associated with high in-hospital death rate. In conclusion, MS is an important predictor for in-hospital death in patients with STEMI.
Acute Disease
;
Age Factors
;
Aged
;
C-Reactive Protein/analysis
;
Cholesterol, LDL/blood
;
Coronary Angiography
;
Female
;
Humans
;
Male
;
Metabolic Syndrome X/*complications/epidemiology
;
Middle Aged
;
Multivariate Analysis
;
Myocardial Infarction/*complications/mortality/therapy
;
Predictive Value of Tests
;
Prognosis
;
Treatment Outcome
;
Ventricular Dysfunction, Left/complications/physiopathology
8.Comparison of Clinical Outcomes Following Acute Myocardial Infarctions in Hypertensive Patients With or Without Diabetes.
Min Goo LEE ; Myung Ho JEONG ; Youngkeun AHN ; Shung Chull CHAE ; Seung Ho HUR ; Taek Jong HONG ; Young Jo KIM ; In Whan SEONG ; Jei Keon CHAE ; Jay Young RHEW ; In Ho CHAE ; Myeong Chan CHO ; Jang Ho BAE ; Seung Woon RHA ; Chong Jim KIM ; Donghoon CHOI ; Yang Soo JANG ; Junghan YOON ; Wook Sung CHUNG ; Jeong Gwan CHO ; Ki Bae SEUNG ; Seung Jung PARK
Korean Circulation Journal 2009;39(6):243-250
BACKGROUND AND OBJECTIVES: It is thought that patients with diabetes mellitus (DM) have a poor prognosis after an acute myocardial infarction (AMI), but the effect of diabetes on the outcomes of hypertensive patients with AMIs has not been elucidated in the Korean population. The aim of this study was to investigate the effects of diabetes on long-term clinical outcomes following AMIs in patients with hypertension. SUBJECTS AND METHODS: Using data from the Korea Acute Myocardial Infarction Registry (November 2005 to December 2006), 2,233 hypertensive patients with AMIs were grouped as follows based on the presence of DM: group I, diabetic hypertension (n=892, 544 men, mean age=66.2+/-10.9 years); and group II, non-diabetic hypertension (n=1341, 938 men, mean age=63.9+/-12.8 years). The primary study outcomes included in-hospital death and major adverse cardiac events (MACE; cardiac death, myocardial infarction (MI), repeat percutaneous coronary intervention, and coronary artery bypass surgery) at the 1 year follow-up. RESULTS: Hypertensive patients with DM were older and more likely to be women. The diabetic group had lower blood pressure (p<0.001), a lower left ventricular ejection fraction (p<0.001), a more severe degree of heart failure (p<0.001), a longer duration of coronary care unit admission (p<0.001), and a higher incidence of hyperlipidemia (p=0.007). The N-terminal pro-brain natriuretic peptide level (4602.5+/-8710.6 pg/mL vs. 2320.8+/-5837.9 pg/mL, p<0.001) was higher and the creatinine clearance (62.4+/-29.9 mL/min vs. 73.0+/-40.8 mL/min, p<0.001) was lower in the diabetic group than the non-diabetic group. Coronary angiographic findings revealed more frequent involvement of the left main stem (p=0.002) and multiple vessels (p<0.001) in the diabetic group. The rate of in-hospital death was higher in the diabetic group (p<0.001). During follow-up, the rates of composite MACE at 1 month, 6 months, and 12 months were higher in the diabetic group (p<0.001). CONCLUSION: In hypertensive patients with AMI, DM was associated with worse clinical and angiographic features, with a higher risk of development of severe heart failure, and an increased risk of MACE on long-term clinical follow-up.
Blood Pressure
;
Coronary Artery Bypass
;
Coronary Care Units
;
Creatinine
;
Death
;
Diabetes Mellitus
;
Female
;
Follow-Up Studies
;
Heart Failure
;
Humans
;
Hyperlipidemias
;
Hypertension
;
Incidence
;
Korea
;
Male
;
Myocardial Infarction
;
Percutaneous Coronary Intervention
;
Prognosis
;
Stroke Volume
9.Comparison of Drug-Eluting Stents in Acute Myocardial Infarction Patients with Chronic Kidney Disease.
Daisuke HACHINOHE ; Myung Ho JEONG ; Shigeru SAITO ; Min Chol KIM ; Kyung Hoon CHO ; Khurshid AHMED ; Seung Hwan HWANG ; Min Goo LEE ; Doo Sun SIM ; Keun Ho PARK ; Ju Han KIM ; Young Joon HONG ; Youngkeun AHN ; Jung Chaee KANG ; Jong Hyun KIM ; Shung Chull CHAE ; Young Jo KIM ; Seung Ho HUR ; In Whan SEONG ; Taek Jong HONG ; Donghoon CHOI ; Myeong Chan CHO ; Chong Jin KIM ; Ki Bae SEUNG ; Wook Sung CHUNG ; Yang Soo JANG ; Seung Woon RHA ; Jang Ho BAE ; Seung Jung PARK
The Korean Journal of Internal Medicine 2012;27(4):397-406
BACKGROUND/AIMS: To determine which drug-eluting stents are more effective in acute myocardial infarction (MI) patients with chronic kidney disease (CKD). METHODS: This study included a total of 3,566 acute MI survivors with CKD from the Korea Acute Myocardial Infarction Registry who were treated with stenting and followed up for 12 months: 1,845 patients who received sirolimus-eluting stents (SES), 1,356 who received paclitaxel-eluting stents (PES), and 365 who received zotarolimus-eluting stents (ZES). CKD was defined as an estimated glomerular filtration rate < 60 mL/min/1.73 m2 calculated by the modification of diet in renal disease method. RESULTS: At the 12-month follow-up, patients receiving ZES demonstrated a higher incidence (14.8%) of major adverse cardiac events (MACEs) compared to those receiving SES (10.1%) and PES (12%, p = 0.019). The ZES patients also had a higher incidence (3.9%) of target lesion revascularization (TLR) compared to those receiving SES (1.5%) and PES (2.4%, p = 0.011). After adjusting for confounding factors, ZES was associated with a higher incidence of MACE and TLR than SES (adjusted hazard ratio [HR], 0.623; 95% confidence interval [CI], 0.442 to 0.879; p = 0.007; adjusted HR, 0.350; 95% CI, 0.165 to 0.743; p = 0.006, respectively), and with a higher rate of TLR than PES (adjusted HR, 0.471; 95% CI, 0.223 to 0.997; p = 0.049). CONCLUSIONS: Our findings suggest that ZES is less effective than SES and PES in terms of 12-month TLR, and has a higher incidence of MACE due to a higher TLR rate compared with SES, in acute MI patients with CKD.
Aged
;
*Drug-Eluting Stents/adverse effects
;
Female
;
Humans
;
Male
;
Middle Aged
;
Myocardial Infarction/*etiology/mortality/*therapy
;
Paclitaxel/administration & dosage
;
Prospective Studies
;
Registries
;
Renal Insufficiency, Chronic/*complications
;
Republic of Korea/epidemiology
;
Sirolimus/administration & dosage/analogs & derivatives
10.Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.
Min Seok KIM ; Ju Hee LEE ; Eung Ju KIM ; Dae Gyun PARK ; Sung Ji PARK ; Jin Joo PARK ; Mi Seung SHIN ; Byung Su YOO ; Jong Chan YOUN ; Sang Eun LEE ; Sang Hyun IHM ; Se Yong JANG ; Sang Ho JO ; Jae Yeong CHO ; Hyun Jai CHO ; Seonghoon CHOI ; Jin Oh CHOI ; Seong Woo HAN ; Kyung Kuk HWANG ; Eun Seok JEON ; Myeong Chan CHO ; Shung Chull CHAE ; Dong Ju CHOI
Korean Circulation Journal 2017;47(5):555-643
The prevalence of heart failure (HF) is skyrocketing worldwide, and is closely associated with serious morbidity and mortality. In particular, HF is one of the main causes for the hospitalization and mortality in elderly individuals. Korea also has these epidemiological problems, and HF is responsible for huge socioeconomic burden. However, there has been no clinical guideline for HF management in Korea.
The present guideline provides the first set of practical guidelines for the management of HF in Korea and was developed using the guideline adaptation process while including as many data from Korean studies as possible. The scope of the present guideline includes the definition, diagnosis, and treatment of chronic HF with reduced/preserved ejection fraction of various etiologies.
Aged
;
Diagnosis*
;
Heart Failure*
;
Heart*
;
Hospitalization
;
Humans
;
Korea
;
Mortality
;
Prevalence